Ginsenoside Rg1 Improves Inflammation and Autophagy of the Pancreas and Spleen in Streptozotocin-Induced Type 1 Diabetic Mice.

IF 2.3 4区 医学 Q3 ENDOCRINOLOGY & METABOLISM
Yi Zong, Weihua Yu, Hanghang Hong, Zhiqiang Zhu, Wenbo Xiao, Kewu Wang, Guoqiang Xu
{"title":"Ginsenoside Rg1 Improves Inflammation and Autophagy of the Pancreas and Spleen in Streptozotocin-Induced Type 1 Diabetic Mice.","authors":"Yi Zong,&nbsp;Weihua Yu,&nbsp;Hanghang Hong,&nbsp;Zhiqiang Zhu,&nbsp;Wenbo Xiao,&nbsp;Kewu Wang,&nbsp;Guoqiang Xu","doi":"10.1155/2023/3595992","DOIUrl":null,"url":null,"abstract":"<p><strong>Background: </strong>Ginsenoside Rg1 (Rg1) is one of the key bioactive components of the precious Traditional Chinese Medicine that has been used to treat diabetes in China. Ginsenosides have been reported to protect diabetics from tissue damage, inflammation, and insulin resistance. Type 1 diabetes (T1D) is an organ-specific autoimmune disease that occurred frequently among adolescents over the world, its development was related to inflammation and <i>β</i>-cells immunodeficiency. The aim of this study is to explore the biological mechanism of Rg1 on inflammation and autophagy of <i>β</i>-cells in T1D and its therapeutic potential.</p><p><strong>Methods: </strong>The model of T1D mice was established by injecting Streptozotocin (STZ) (55 mg/kg) or citric acids once a day for 5 days and from the fourth day of injection, mice were administered with Rg1 (20 mg/kg) or saline by gavage once a day for 12 days. Hematoxylin-eosin staining, immunofluorescence, ELISA, quantitative real-time PCR, and Western blot were used to observe the histopathological changes, inflammatory factor levels, and autophagy markers after administration of ginsenoside Rg1.</p><p><strong>Results: </strong>Compared to the T1D mice, Rg1 improved the weight (<i>p</i> < 0.05) and blood glucose (<i>p</i> < 0.01) of mice, advanced the injury and apoptosis of <i>β</i>-cells in islets (<i>p</i> < 0.01), and markedly inhibited the protein expression degrees of CD45, CXCL16, ox-LDL, and TF in the pancreas and spleens (<i>p</i> < 0.01), also activated the degrees of insulin in serum (<i>p</i> < 0.01). Besides, in T1D mice' pancreas and spleen, Rg1 markedly repressed the IL-1<i>β</i>, TNF-<i>α</i>, and NOS2 mRNA levels (<i>p</i> < 0.05 or <i>p</i> < 0.01), inhibited the CXCL16, NF-<i>κ</i>B, and TF proteins (<i>p</i> < 0.05 or <i>p</i> < 0.01), while elevating the ratio of LC3 II/I (<i>p</i> < 0.01) and P62 (<i>p</i> < 0.05) protein level.</p><p><strong>Conclusions: </strong>This study proved that Rg1 protected mice against T1D possibly by improving islet injury and tissue inflammation, raising serum insulin, and tissue autophagy marker.</p>","PeriodicalId":13966,"journal":{"name":"International Journal of Endocrinology","volume":null,"pages":null},"PeriodicalIF":2.3000,"publicationDate":"2023-01-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10030220/pdf/","citationCount":"1","resultStr":null,"platform":"Semanticscholar","paperid":null,"PeriodicalName":"International Journal of Endocrinology","FirstCategoryId":"3","ListUrlMain":"https://doi.org/10.1155/2023/3595992","RegionNum":4,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":null,"EPubDate":"","PubModel":"","JCR":"Q3","JCRName":"ENDOCRINOLOGY & METABOLISM","Score":null,"Total":0}
引用次数: 1

Abstract

Background: Ginsenoside Rg1 (Rg1) is one of the key bioactive components of the precious Traditional Chinese Medicine that has been used to treat diabetes in China. Ginsenosides have been reported to protect diabetics from tissue damage, inflammation, and insulin resistance. Type 1 diabetes (T1D) is an organ-specific autoimmune disease that occurred frequently among adolescents over the world, its development was related to inflammation and β-cells immunodeficiency. The aim of this study is to explore the biological mechanism of Rg1 on inflammation and autophagy of β-cells in T1D and its therapeutic potential.

Methods: The model of T1D mice was established by injecting Streptozotocin (STZ) (55 mg/kg) or citric acids once a day for 5 days and from the fourth day of injection, mice were administered with Rg1 (20 mg/kg) or saline by gavage once a day for 12 days. Hematoxylin-eosin staining, immunofluorescence, ELISA, quantitative real-time PCR, and Western blot were used to observe the histopathological changes, inflammatory factor levels, and autophagy markers after administration of ginsenoside Rg1.

Results: Compared to the T1D mice, Rg1 improved the weight (p < 0.05) and blood glucose (p < 0.01) of mice, advanced the injury and apoptosis of β-cells in islets (p < 0.01), and markedly inhibited the protein expression degrees of CD45, CXCL16, ox-LDL, and TF in the pancreas and spleens (p < 0.01), also activated the degrees of insulin in serum (p < 0.01). Besides, in T1D mice' pancreas and spleen, Rg1 markedly repressed the IL-1β, TNF-α, and NOS2 mRNA levels (p < 0.05 or p < 0.01), inhibited the CXCL16, NF-κB, and TF proteins (p < 0.05 or p < 0.01), while elevating the ratio of LC3 II/I (p < 0.01) and P62 (p < 0.05) protein level.

Conclusions: This study proved that Rg1 protected mice against T1D possibly by improving islet injury and tissue inflammation, raising serum insulin, and tissue autophagy marker.

人参皂苷Rg1改善链脲佐菌素诱导的1型糖尿病小鼠胰腺和脾脏的炎症和自噬
背景:人参皂苷Rg1 (Ginsenoside Rg1)是中药中重要的生物活性成分之一,在中国已被用于治疗糖尿病。据报道,人参皂苷可以保护糖尿病患者免受组织损伤、炎症和胰岛素抵抗。1型糖尿病(T1D)是一种常见于世界各地青少年的器官特异性自身免疫性疾病,其发展与炎症和β细胞免疫缺陷有关。本研究旨在探讨Rg1对T1D中β-细胞炎症和自噬的生物学机制及其治疗潜力。方法:通过注射链脲佐菌素(STZ) (55 mg/kg)或柠檬酸,每天1次建立T1D小鼠模型,连续5 d,从注射第4天开始,小鼠灌胃Rg1 (20 mg/kg)或生理盐水,每天1次,连续12 d。采用苏木精-伊红染色、免疫荧光、ELISA、实时荧光定量PCR、Western blot等方法观察人参皂苷Rg1给药后的组织病理变化、炎症因子水平及自噬标志物。结果:与T1D小鼠相比,Rg1改善了小鼠体重(p < 0.05)和血糖(p < 0.01),促进了胰岛β-细胞的损伤和凋亡(p < 0.01),显著抑制了胰腺和脾脏中CD45、CXCL16、ox-LDL和TF的蛋白表达度(p < 0.01),激活了血清中胰岛素的水平(p < 0.01)。在T1D小鼠胰腺和脾脏中,Rg1显著抑制IL-1β、TNF-α和NOS2 mRNA水平(p < 0.05或p < 0.01),抑制CXCL16、NF-κB和TF蛋白水平(p < 0.05或p < 0.01),升高LC3 II/I比值(p < 0.01)和P62蛋白水平(p < 0.05)。结论:本研究证明Rg1可能通过改善胰岛损伤和组织炎症,提高血清胰岛素和组织自噬标志物来保护小鼠抗T1D。
本文章由计算机程序翻译,如有差异,请以英文原文为准。
求助全文
约1分钟内获得全文 求助全文
来源期刊
International Journal of Endocrinology
International Journal of Endocrinology ENDOCRINOLOGY & METABOLISM-
CiteScore
5.20
自引率
0.00%
发文量
147
审稿时长
1 months
期刊介绍: International Journal of Endocrinology is a peer-reviewed, Open Access journal that provides a forum for scientists and clinicians working in basic and translational research. The journal publishes original research articles, review articles, and clinical studies that provide insights into the endocrine system and its associated diseases at a genomic, molecular, biochemical and cellular level.
×
引用
GB/T 7714-2015
复制
MLA
复制
APA
复制
导出至
BibTeX EndNote RefMan NoteFirst NoteExpress
×
提示
您的信息不完整,为了账户安全,请先补充。
现在去补充
×
提示
您因"违规操作"
具体请查看互助需知
我知道了
×
提示
确定
请完成安全验证×
copy
已复制链接
快去分享给好友吧!
我知道了
右上角分享
点击右上角分享
0
联系我们:info@booksci.cn Book学术提供免费学术资源搜索服务,方便国内外学者检索中英文文献。致力于提供最便捷和优质的服务体验。 Copyright © 2023 布克学术 All rights reserved.
京ICP备2023020795号-1
ghs 京公网安备 11010802042870号
Book学术文献互助
Book学术文献互助群
群 号:481959085
Book学术官方微信